Literature DB >> 17401688

The role of smoking in Crohn's disease as defined by clinical variables.

Suhal S Mahid1, Kyle S Minor, Patrick L Stevens, Susan Galandiuk.   

Abstract

The development of Crohn's disease (CD) is related to an interaction of genetic and environmental factors, with tobacco smoking being one of the most commonly studied environmental factors. In 1998, the Vienna classification was created to define CD by using three accepted clinical variables: age at diagnosis, disease behavior, and disease location. In this qualitative systematic review, articles examining the relationship between smoking and CD, using variables outlined in the Vienna classification, were identified utilizing multiple health databases. Current smoking was found to be associated with late-onset CD (> or =40 years old) and current smokers were more likely to progress to stricturing or penetrating type CD than were nonsmoking patients. Conflicting evidence exists regarding the relationship between smoking with respect to CD disease location. The Vienna classification is an important tool in permitting comparisons and predicting clinical course among CD cases, especially when smoking status is taken into account.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401688     DOI: 10.1007/s10620-006-9624-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Inflammatory bowel disease and tobacco smoke--a case-control study.

Authors:  P G Persson; A Ahlbom; G Hellers
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

2.  Active and passive smoking in childhood is related to the development of inflammatory bowel disease.

Authors:  Suhal S Mahid; Kyle S Minor; Arnold J Stromberg; Susan Galandiuk
Journal:  Inflamm Bowel Dis       Date:  2007-04       Impact factor: 5.325

3.  Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.

Authors:  A J Greenstein; P Lachman; D B Sachar; J Springhorn; T Heimann; H D Janowitz; A H Aufses
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

4.  Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activity.

Authors:  F T Veloso; J T Ferreira; L Barros; S Almeida
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

5.  Should patients with inflammatory bowel disease smoke?

Authors:  G Holdstock; D Savage; M Harman; R Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-04

6.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

7.  Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes.

Authors:  Steven R Brant; Michael F Picco; Jean-Paul Achkar; Theodore M Bayless; Sunanda V Kane; Aaron Brzezinski; Franklin J Nouvet; Denise Bonen; Amir Karban; Themistocles Dassopoulos; Reda Karaliukas; Terri H Beaty; Stephen B Hanauer; Richard H Duerr; Judy H Cho
Journal:  Inflamm Bowel Dis       Date:  2003-09       Impact factor: 5.325

8.  Relationship between smoking and colonic involvement in inflammatory bowel disease.

Authors:  M Bustamante; P Nos; M Hoyos; J Hinojosa; J R Molés; A García-Herola; J Berenguer
Journal:  Rev Esp Enferm Dig       Date:  1998-12       Impact factor: 2.086

9.  The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

10.  Risk factors for early postoperative recurrence of Crohn's disease.

Authors:  E Lautenbach; J A Berlin; G R Lichtenstein
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  20 in total

1.  Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Authors:  M Severs; S J H van Erp; M E van der Valk; M J J Mangen; H H Fidder; M van der Have; A A van Bodegraven; D J de Jong; C J van der Woude; M J L Romberg-Camps; C H M Clemens; J M Jansen; P C van de Meeberg; N Mahmmod; C Y Ponsioen; C Bolwerk; J R Vermeijden; M J Pierik; P D Siersema; M Leenders; A E van der Meulen-de Jong; G Dijkstra; B Oldenburg
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

Review 2.  Smoking in inflammatory bowel diseases: good, bad or ugly?

Authors:  Peter Laszlo Lakatos; Tamas Szamosi; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

3.  Pancreatic cancer patients who smoke and drink are diagnosed at younger ages.

Authors:  Randall E Brand; Julia B Greer; Eugene Zolotarevsky; Rhonda Brand; Hongyan Du; Diane Simeone; Anna Zisman; Addi Gorchow; Shih-Yuan Connie Lee; Hemant K Roy; Michelle A Anderson
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-26       Impact factor: 11.382

Review 4.  Influence of environmental factors in the development of inflammatory bowel diseases.

Authors:  Evangelia Legaki; Maria Gazouli
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

5.  Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.

Authors:  Tiago Nunes; Maria Josefina Etchevers; Valle García-Sánchez; Daniel Ginard; Eva Martí; Manuel Barreiro-de Acosta; Fernando Gomollón; Maite Arroyo; Guillermo Bastida; Benito Gonzalez; David Monfort; Esther García-Planella; Carolina Figueroa; Julián Panés; Miquel Sans
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

6.  Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.

Authors:  Grace Gathungu; Mi-Ok Kim; John P Ferguson; Yashoda Sharma; Wei Zhang; Sok Meng E Ng; Erin Bonkowski; Kaida Ning; Lisa A Simms; Anthony R Croft; Joanne M Stempak; Nicole Walker; Ning Huang; Yang Xiao; Mark S Silverberg; Bruce Trapnell; Judy H Cho; Graham L Radford-Smith; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

7.  Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.

Authors:  Barbara Dorottya Lovasz; Laszlo Lakatos; Agnes Horvath; Istvan Szita; Tunde Pandur; Michael Mandel; Zsuzsanna Vegh; Petra Anna Golovics; Gabor Mester; Mihaly Balogh; Csaba Molnar; Erzsebet Komaromi; Lajos Sandor Kiss; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

8.  Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.

Authors:  Peter Laszlo Lakatos; Zsofia Czegledi; Tamas Szamosi; Janos Banai; Gyula David; Ferenc Zsigmond; Tunde Pandur; Zsuzsanna Erdelyi; Orsolya Gemela; Janos Papp; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

9.  Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database.

Authors:  Edward L Barnes; Renee M Beery; Allison R Schulman; Ellen P McCarthy; Joshua R Korzenik; Rachel W Winter
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

10.  Influence of smoking on colonic gene expression profile in Crohn's disease.

Authors:  Ole Haagen Nielsen; Jacob Tveiten Bjerrum; Claudio Csillag; Finn Cilius Nielsen; Jørgen Olsen
Journal:  PLoS One       Date:  2009-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.